Jin Rong Jie·2025-08-18 08:45Group 1 - The Shanghai Composite Index rose by 0.85% to close at 3728.03 points, while the Hang Seng Index fell by 0.37% to close at 25176.85 points [1] - The premium of Haiprui's A-shares over H-shares reached 116.58%, ranking 19th among AH shares [1] - Haiprui's A-shares closed at 13.28 yuan with a 0.3% increase, and H-shares closed at 6.68 HKD with a 0.91% increase [1] Group 2 - Shenzhen Haiprui Pharmaceutical Group Co., Ltd. was established in 1998 and is a leading multinational pharmaceutical company with A+H dual financing platforms [1] - The company operates across the entire heparin industry chain, biopharmaceutical CDMO, and the investment, development, and commercialization of innovative drugs [1] - Haiprui's three business segments are synergistic and driven by unmet clinical needs, aiming to provide high-quality, safe, and effective drugs and services to global patients [1]